STAT3 and neoplasm: Blocking tumor-induced myelopoiesis [45], the recruitment of monocytes to the tumor microenvironment, e.g., through blockade of chemokine receptors, the conversion of monocytes into Mo-MDSC, and the STAT3-dependent enhancement of tumor stemness all offer opportunities to thwart the tumor-promoting effects on myeloid cells in this disease.